Structural Elucidation of a Novel Lipooligosaccharide from the Antarctic Bacterium OMVs Producer Shewanella sp. HM13

Structural Elucidation of a Novel Lipooligosaccharide from the Antarctic Bacterium OMVs Producer Shewanella sp. HM13

Shewanella sp. HM13 is a cold-adapted Gram-negative bacterium isolated from the intestine of a horse mackerel. It produces a large amount of outer membrane vesicles (OMVs), which are particles released in the medium where the bacterium is cultured. This strain biosynthesizes a single major cargo pro...

Full description

Bibliographic Details
Main Authors:	Angela Casillo, Rossella Di Guida, Sara Carillo, Chen Chen, Kouhei Kamasaka, Jun Kawamoto, Tatsuo Kurihara, Maria Michela Corsaro
Format:	Article
Language:	English
Published:	MDPI AG 2019-01-01
Series:	Marine Drugs
Subjects:	psychrophile lipooligosaccharide (LOS) structure elucidation NMR spectroscopy outer membrane vesicles (OMVs) MALDI-TOF mass spectrometry cold adaptation
Online Access:	http://www.mdpi.com/1660-3397/17/1/34

Similar Items

Detailed Structural Characterization of the Lipooligosaccharide from the Extracellular Membrane Vesicles of <i>Shewanella vesiculosa</i> HM13
by: Rossella Di Guida, et al.
Published: (2020-04-01)

The Glaesserella parasuis phosphoglucomutase is partially required for lipooligosaccharide synthesis
by: Saixiang Feng, et al.
Published: (2020-07-01)

Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine
by: Sunita Gulati, et al.
Published: (2019-02-01)

Mycobacterium marinum mmar_2318 and mmar_2319 are Responsible for Lipooligosaccharide Biosynthesis and Virulence towards Dictyostelium
by: Yi-Yin eChen, et al.
Published: (2016-01-01)

Characterization of Acinetobacter baumannii core oligosaccharide synthesis reveals novel aspects of lipooligosaccharide assembly
by: Leah M. VanOtterloo, et al.
Published: (2024-03-01)

The Immunostimulatory Capacity of Nontypeable Haemophilus influenzae Lipooligosaccharide
by: Gabrielle N. Gaultier, et al.
Published: (2017-02-01)

A novel vaccine formulation candidate based on lipooligosaccharides and pertussis toxin against Bordetella pertussis
by: Jingjing Gao, et al.
Published: (2023-04-01)

Immunological efficiency of Haemophilus influenzae type b polyribosyl ribitol phosphate combined with detoxified lipooligosaccharide in a rabbit model
by: Amin Arsang, et al.
Published: (2025-02-01)

Structure of the Lipooligosaccharide from the Deep-Sea Marine Bacterium <i>Idiomarina zobellii</i> KMM 231<sup>T</sup>, Isolated at a Depth of 4000 Meters
by: Maxim S. Kokoulin, et al.
Published: (2022-11-01)

Pertussis vaccines and the role of <I>Bordetella pertussis</I> lipooligosaccharide in the immune response to pertussis infection and vaccination
by: I. A. Alekseeva, et al.
Published: (2021-03-01)

Lipooligosaccharide Ligands from Respiratory Bacterial Pathogens Enhance Cellular Uptake of Nanoparticles
by: Mai H. Tu, et al.
Published: (2023-03-01)

Assessment of PhtD C-Terminal Immunogenicity by Opsonophagocytosis Assay (OPA) with OMVs as Adjuvants
by: Mohammadali Malekan, et al.
Published: (2019-12-01)

Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine
by: Alberto Grandi, et al.
Published: (2023-09-01)

Modelos de negocios para OMV en el Ecuador
by: Juan Inga, et al.
Published: (2013-06-01)

Impact of meningococcal group B OMV vaccines, beyond their brief
by: Helen Petousis-Harris
Published: (2018-05-01)

Genomic Analysis of the Deep-Sea Bacterium <i>Shewanella</i> sp. MTB7 Reveals Backgrounds Related to Its Deep-Sea Environment Adaptation
by: Sicong Li, et al.
Published: (2023-03-01)

Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines
by: Emanuelle B. Gaspar, et al.
Published: (2021-09-01)

Enhancing immune responses of ESC-based TAA cancer vaccines with a novel OMV delivery system
by: Meiling Jin, et al.
Published: (2024-01-01)

Intranasal delivery of Salmonella OMVs decorated with Chlamydia trachomatis antigens induces specific local and systemic immune responses
by: Dung T. Huynh, et al.
Published: (2024-12-01)

Neisseria gonorrhoeae lipooligosaccharide glycan epitopes recognized by bactericidal IgG antibodies elicited by the meningococcal group B-directed vaccine, MenB-4C
by: Yih-Ling Tzeng, et al.
Published: (2024-02-01)

Salmonella Typhimurium derived OMV nanoparticle displaying mixed heterologous O-antigens confers immunogenicity and protection against STEC infections in mice
by: Xiaoping Bian, et al.
Published: (2025-01-01)

Caveolin-1 regulates OMV-induced macrophage pro-inflammatory activation and multiple Toll-like receptors
by: Ayyanar Sivanantham, et al.
Published: (2023-02-01)

Novel Clinical <i>Campylobacter jejuni</i> Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis
by: Soraya Mousavi, et al.
Published: (2020-03-01)

Outer Membrane Vesicles (OMVs) of Gram-negative Bacteria: A Perspective Update
by: Arif Tasleem Jan
Published: (2017-06-01)

Complete Lipooligosaccharide Structure from <i>Pseudoalteromonas nigrifaciens</i> Sq02-Rif<sup>r</sup> and Study of Its Immunomodulatory Activity
by: Rossella Di Guida, et al.
Published: (2021-11-01)

Modulation of OMV Production by the Lysis Module of the DLP12 Defective Prophage of <i>Escherichia coli K12</i>
by: Martina Pasqua, et al.
Published: (2021-02-01)

Heterologous Display of <i>Chlamydia trachomatis</i> PmpD Passenger at the Surface of <i>Salmonella</i> OMVs
by: Dung T. Huynh, et al.
Published: (2023-03-01)

Immunogenicity of <i>Escherichia coli</i> Outer Membrane Vesicles: Elucidation of Humoral Responses against OMV-Associated Antigens
by: Lorenzo Croia, et al.
Published: (2023-11-01)

<i>Helicobacter pylori</i>-Derived Outer Membrane Vesicles (OMVs): Role in Bacterial Pathogenesis?
by: Miroslaw Jarzab, et al.
Published: (2020-08-01)

β-lactam-induced OMV release promotes polymyxin tolerance in Salmonella enterica sv. Typhi
by: Pedro Marchant, et al.
Published: (2024-03-01)

Preclinical evaluation of OMVs as potential vaccine candidates against Salmonella enterica serovar Enteritidis infection
by: Xi Jiang, et al.
Published: (2022-10-01)

Bacterial Outer Membrane Vesicles (OMVs)-Based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV
by: Mahmoud M. Shehata, et al.
Published: (2019-05-01)

Bioconversion From Docosahexaenoic Acid to Eicosapentaenoic Acid in the Marine Bacterium Shewanella livingstonensis Ac10
by: Takuya Ogawa, et al.
Published: (2020-05-01)

Cryopreservation of Cyanobacteria and Eukaryotic Microalgae Using Exopolysaccharide Extracted from a Glacier Bacterium
by: Pervaiz Ali, et al.
Published: (2021-02-01)

Comparative dynamic studies of marine psychrophilic lipase with mesophilic and thermophilic homologues /
by: Noor Hafizoh Md. Lazim, 1991-, author, et al.
Published: (2014)

Comparative dynamic studies of marine psychrophilic lipase with mesophilic and thermophilic homologues [electronic resource] /
by: Noor Hafizoh Md. Lazim, 1991-, author
Published: (2014)

A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine against N. meningitidis serogroup B and C
by: Yordanka Masforrol, et al.
Published: (2017-11-01)

Activation of the l-fucose utilization cluster in Campylobacter jejuni induces proteomic changes and enhances Caco-2 cell invasion and fibronectin binding
by: Pjotr S. Middendorf, et al.
Published: (2024-08-01)

Neisseria gonorrhoeae scavenges host sialic acid for Siglec-mediated, complement-independent suppression of neutrophil activation
by: Amaris J. Cardenas, et al.
Published: (2024-05-01)

Outer Membrane Vesicles (OMVs) of <i>Pseudomonas aeruginosa</i> Provide Passive Resistance but Not Sensitization to LPS-Specific Phages
by: Daria Augustyniak, et al.
Published: (2022-01-01)